おすすめコンテンツ

製薬企業の臨床開発と顧客エンゲージメントにおける課題と今後の論点

製薬企業にとって重要性が高く、かつ、データやテクノロジーを適切に活用することで大きな効果が見込まれる「臨床開発」と「顧客エンゲージメント」の現状とペインポイント、今後考えるべき論点を見ていきます。

イノベーションの推進と国民皆保険制度の維持

日本の将来を考えるにあたり、国民の日々の安心が守られ、必要な革新的医薬品が国民に遅滞なく届くよう、国民皆保険制度を維持しつつ、戦略産業の観点からもイノベーションを推進し、国力を高めることが重要です。医薬品に焦点を当て、日本における課題と議論を整理し、薬価制度、薬事制度といった具体的な取り組みについて考察します。

実践 BCG流 病院経営――バリューベース・ヘルスケア時代の病院経営

さまざまな医療機関への経営改善支援の経験を基に、医療の質と生産性をともに高めるための考え方と実践的手法について解説します。経営層と現場が一体となった経営改善活動の推進に向け明日から取り組める打ち手が盛り込まれています。

Biopharma

Toward a More Proactive Health Care System

Dr. Alexandra Bause explains how today’s reactive approach provides sick care, not health care—and how biopharma strives to change that.

For Pharmaceutical Companies, Three Steps to Value with Generative AI

New GenAI offerings can benefit virtually every aspect of an organization, boosting efficiency and productivity in areas ranging from R&D to commercial activities.

How Biopharma Can Make a Difference in Health Equity

By leveraging innovative business models and partnerships, biopharma companies could reach patients in low- and middle-income countries at no extra cost.

The Inflation Reduction Act’s Ripple Effects on the US Health Care Ecosystem

The IRA provisions concerning the pricing of drugs for Medicare patients are creating new economic realities for health care players.

A Strategic Approach to Cost in Biopharma

Manufacturing costs are rising rapidly, with no end in sight. Leaders that balance the various tradeoffs can remain competitive over the long run.

Next-Generation Commercial Models

The Second Opinion That Unlocks Best-in-Class Pharma Launches

The Team B approach involves assembling an independent cross-functional team to conduct rapid reviews of launch plans and market conditions for new pharmaceutical products.

Bold Advances in Health Care

Biogen’s CFO on Leading a People-First Transformation

Mike McDonnell explains how the global biotech is charting new paths to patientsvia Fit for Growth, its corporate transformation initiative.

Pfizer’s Digital Transformation

Chief Digital and Technology Officer Lidia Fonseca explains how Pfizer is leveraging digital and data across the value chain and the biggest wins so far.

CEO Paul Hudson on Sanofi’s Climate Ambition

Hudson discusses the company’s commitment to reaching net zero emissions by 2045.

CEO Richard Francis on the Talent Behind Teva’s Success

Francis discusses the role that Teva’s people are playing in the execution of the company’s new growth strategy.

Personalized: Customer Strategy in the Age of AI

Personalization is a $2 trillion opportunity. BCG's new book offers a playbook for capturing your share of this personalization prize in the health care industry.

Learn More About Personalized
Benchmark Your Personalization Readiness Now

Health Care Payers, Providers, Systems, and Services

In Health Care, Maximizing AI Is About Managing Change

Health care companies can unlock AI's potential and drive sales growth by prioritizing change management—not just technology—says BCG’s Basir Mustaghni.

Facing Headwinds, Health Systems Can Learn from Airlines

To thrive during turbulent economic times, health systems can learn from the aviation industry, which embraced novel diversification approaches to maintain revenue stability and improve profitability.

BCG-WEF Project: Digital Health Care Transformation

While digital, data, and AI have extraordinary potential to revolutionize our global health care systems, they have yet to deliver a transformative impact. How can the public and private sectors accelerate progress?

Are Payers and Providers Ready for Digital Change in Health Care?

The latest technologies hold tremendous promise for health care, but they also pose significant challenges. Not all organizations are prepared to take advantage of the tech trends.

Medical Devices and Technology

Making Medtech More Equitable

By developing products for a broader base of patients and markets, medtech companies can improve health outcomes, generate business advantages, and contribute to healthier societies overall.

Medtech’s Path to a Circular Future

Most environmental waste generated by the health care sector comes from medtech products. For a sector focused on improving quality of life, reducing waste and greenhouse gases is imperative.

Medtech Companies Must Move Faster on Generative AI

To realize the promise and potential for GenAI, medtech executives must make swift and targeted efforts.

Medtech’s New Era of Collaboration and Innovation

Medtech management teams face an unfamiliar list of questions. The players that can successfully navigate the challenging terrain will be the winners of the 2020s.

Global Health

Addressing Challenges at the Intersection of Climate and Health

BCG conducted a study of more than 70 organizations—including philanthropies, multilateral development banks, government agencies, nongovernmental organizations, private sector actors, and others—to understand how key stakeholders are approaching the climate-health challenge.

Human Health Depends on Planetary Health

Too often is it taken for granted that the environment is a massive determinant of human well-being. Putting health at the center of our climate discussions is critical.

Embedding Health Equity into the Heart of Biopharma

The biopharma industry faces demands for more action to address health inequities. We provide a guide and tools to help companies integrate equity across the product lifecycle.

Reimagining Global Health After the Coronavirus

What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?

• 

  Anticipating the Spread of COVID-19 with Scenario Planning

  BCG’s scenario-planning tool, PLAN, helps you explore the potential impact of COVID-19 in the United States at a region, state, and county level.
• 

  BD’s Vincent Forlenza on Transforming in a Rapidly Changing Industry

  Vincent Forlenza, CEO of BD, has navigated multibillion-dollar acquisitions while driving a full-scale organizational transformation. BD’s success, amid enormous change, hinges on its purpose-driven culture.
• 

  Accelerating Drug Development Today

  Sit in on a conversation with BCG pharma leaders as they discuss advancing drug development with new tools, real-world data, digitization, and collaboration across cross-functional teams.
• 

  Using Big Data to Measure Health Care Outcomes

  According to BCG's Sanjay Saxena, the opportunity for using big data and analytics in measuring outcomes is huge. But the trick for payers and providers will be understanding the data—and knowing which questions to ask about it.
• 

  Jon Kaplan on Health Care Payers

  BCG’s Jon Kaplan explains how health care payers can provide the strongest portfolio of product offerings and best service in today’s marketplace.